Hong Kong IVD Registration

IVD registration in Hong Kong, also known as “Listing”, is voluntary under the Medical Device Administrative Control System (MDACS).

Managed by the Medical Device Division (MDD) of the Department of Health, MDACS facilitates pre-market control of medical devices, including IVDs.

Though voluntary, IVD listing is strongly encouraged for procurement purposes by public hospitals, clinics, and the Hospital Authority.

Hong Kong IVD Registration
Voluntary registration in the Hong Kong market

How to List an IVD in Hong Kong

To list an IVD under MDACS, the manufacturer (foreign or local) must appoint a Local Responsible Person (LRP) and submit a registration application to the MDD with:

Class I IVDs: Filing/notification with technical documentation is sufficient. Once approved, the product receives a Certificate of Filing with indefinite validity unless modified.
Class II & III IVDs: Require a full registration process, including type testing, either a China Clinical Trial or a Clinical Evaluation Report (CER), and QMS assessment.

How to List an IVD in Hong Kong

To list an IVD under MDACS, the manufacturer (foreign or local) must appoint a Local Responsible Person (LRP) and submit a registration application to the MDD with:

Scientific and medical writing including Clinical Evaluation Reports (CERs) and Performance Evaluation Reports (PERs)
Essential Principles Conformity Checklist (TR-005) for IVDs
Risk analysis and performance evaluation data
Instructions for use (IFU), labeling, and specimen collection details
Quality management system (QMS) certificate (e.g., ISO 13485)

IVD Conformity Assessment Requirements

The IVD must conform to the Technical Reference TR-005, which outlines the Essential Principles of Safety and Performance specific to IVDs. Depending on the classification, the MDD may request clinical performance data and additional documentation during review. The Conformity Assessment Body (CAB) evaluates whether the product meets these standards.

IVD Risk Classification in Hong Kong

Under the MDACS, Hong Kong applies the IMDRF IVD classification system, dividing IVDs into Classes A, B, C, and D based on risk. Only Classes B, C, and D are eligible for listing under the MDACS, similar to the classification of medical devices in Classes II, III and IV.

The level of regulatory control increases as the risk classification of the devices rises, aligning with international guidelines to ensure compliance during the device registration process.

Class A: Lowest risk – not eligible for listing
Class B-D: Medium to high risk – eligible for voluntary listing.

Why List Your IVD Device in Hong Kong?

Since 1 November 2024, all Department of Health tenders require an MDACS Listing Number or Application Number for IVD devices.
MDACS listing increases credibility and access to public procurement, including Hospital Authority and public clinics.
A listed IVD device gains competitive advantage and is preferred in tenders over unlisted alternatives.
Registration supports Greater Bay Area (GBA) access and may support participation in the GBA Connect Scheme for urgently needed diagnostics in designated hospitals in Guangdong Province, including Shenzhen and Zhuhai.

China Greater Bay Area Connect Scheme for IVDs

The GBA Connect Scheme allows IVD devices without prior approval in China but with reference-country listings to be used in designated GBA hospitals. As of February 2025, 45 hospitals are included in the scheme. Hong Kong listing is a key stepping stone for manufacturers targeting the GBA and mainland China markets.

Our Hong Kong IVD Listing Services

We offer end-to-end support for IVD registration or listing in Hong Kong:

IVD risk classification and listing strategy
Guidance on best regulatory pathways
Labeling and UDI compliance support
Handling of Supplementary Notices, renewals, and post-listing changes.
Preparation and submission of:
  • Hong Kong MDACS Listing
  • GBA Connect applications
  • Expedited approval routes where eligible

Request a Proposal to List Your IVDs in Hong Kong

Let Cisema help turn your plans into reality.

Request Proposal

Useful Articles

View More
No items found.
Previous
Previous

Explore Related Services

Whether you’re just starting out or are a blue-chip, access our wide range of services and outsourcing solutions to help your business thrive.

Hong Kong Local 
Responsible Person

We are your authorized representative in Hong Kong, and fulfill your listings as well as ensuring compliance with PMS requirements.

Hong Kong Medical Device Listing

We’re with you every step of the way in getting your medical device listed in Hong Kong. From risk classification to navigating all regulatory requirements, we streamline the process to save you time and hassle.

China Medical Device Registration

We guide you through every step of the China medical device registration and filing process. We take care of compliance with NMPA requirements, advising you on the optimal market entry pathway, and helping you through the whole process.

Drug Device Combination Products

We assist with the classification, registration, and compliance of combination products in China, whether drug or device led.

Regulatory Outsourcing

If you are seeking specific specialist expertise or have ongoing resource-intensive needs, we have a variety of solutions to meet your needs.

China Clinical Trials

You may be required to provide supplementary clinical data on Chinese patients or conduct a full clinical trial in China.Our clinical research team will advise you, prepare the study protocol and assist setting up the clinical trial in China.

Medical Device PMS & Vigilance

The NMPA is placing greater focus on Post-Market Surveillance (PMS) such as more in-market sampling inspections and regular standard changes.Our specialist PMS team means you stay up to date with the many aspects of compliance.

NMPA Type Testing

Our on-site test engineers coordinate and supervise type tests of your medical devices in NMPA-accredited laboratories.

How We’ve Helped Clients with Our Expert Guidance

Read about how we work with clients to find solutions, bringing together deep industry knowledge with leading talent.

View More
April 18, 2026

China Manufacture License Renewal for Level A2 Pressure Vessels

Cisema supported Inox Torres Group in successfully renewing its China SELO license for Level A2 pressure vessels through expert audit preparation and regulatory guidance.

Learn More
China Manufacture License Renewal for Level A2 Pressure Vessels
Previous
Previous

Latest Insights

View More
There are currently no articles to display in this category.
Previous
Previous

Get in Touch with Our Life Sciences Team

And discover how we can support you in achieving approval in the voluntary system for your in vitro diagnostic in Hong Kong.

Request Proposal